Business Description
Compugen is an Israeli biotech company focused on discovering and developing new cancer treatments, with operations spanning the United States and Europe. Its lead drug candidates work by targeting specific proteins that help tumors evade the immune system, with several currently being tested in clinical trials for various solid tumor cancers, including an advanced study for lung cancer. The company works alongside major pharmaceutical partners, including Bristol-Myers Squibb, AstraZeneca, and Gilead Sciences, to advance its treatments through development and toward the market.
